; exceeds (bb) the MFP+6 payment amount (as so defined) for such drug and calendar quarter, less the MFP+6 coinsurance amount for such drug and calendar quarter; and (II) the amount (if any) by which— (aa) the ASP+6 coinsurance amount (as defined in paragraph (5)) for such drug and calendar quarter; exceeds (bb) the MFP+6 coinsurance amount (as so defined) for such drug and calendar quarter. (iii) The rebate amount specified under subparagraph (B) for such drug and calendar quarter. (B) Manufacturer requirement For each calendar quarter beginning on or after the first day of the initial price applicability period (as defined in section 1191(b)(2)), the manufacturer of a selected drug shall, for such drug, not later than 30 days after the date of receipt from the Secretary of the information described in subparagraph (A) for such calendar quarter, provide to the Secretary a rebate that is equal to the amount specified in subparagraph (A)(ii) multiplied by the number of units specified in subparagraph (A)(i) for such drug for such calendar quarter. The rebate required under this subparagraph shall be in addition to any other rebates required under this title or title XIX, including the payments required under subsections (h) and (i). (2) Calculation of beneficiary coinsurance based on mfp+6 (A) In general Subject to subparagraph (B), in the case of a selected drug with respect to which a rebate is paid under this subsection— (i) the amount of any coinsurance applicable under this part to an individual to whom such drug is furnished during a calendar quarter shall be equal to the MFP+6 coinsurance amount